Dysfunctions of the gastrointestinal tract are thought to be related to disturbances or 10
Introduction
Gastrointestinal tract (GIT) microbiota plays an important role in human health due to its essential participation in digestion and nutrient assimilation, as well as its immune modulating functions. The populations of bacterial species in the gut vary between individuals, they are influenced by the environment and, although flexible, microbial 5 populations in the gut are finely tuned and very sensitive to infectious processes (Kurokawa et al., 2007; Palmer et al., 2007) . Also, the GIT microbial profile varies in immunological or inflammatory disease patients, metabolic syndrome and even in children with autism (Sekirov et al., 2010) . Furthermore, recent findings suggest that specific gut microbial imbalances are associated with enhanced risks of specific 10 diseases. A sensible option to restore the lost balance in a complex microbial community may be the introduction of bacterial species (probiotics) that will restitute it.
Probiotics are defined as "live microorganisms that, when administered in adequate amounts, confer a health benefit to the host" (FAO/WHO, 2002) . They are commonly isolated from human samples and are externally administrated helping in the recovery 15 and maintenance of the microbial balance. Probiotics have become popular in a number of food products which are commercially available worldwide. They are also found with increasing frequency as nutritional supplements, freeze dried in sacchettes or capsules.
Most of them belong to the genera Lactobacillus or Bifidobacterium, although there are remarkable exceptions, such as Saccharomyces boulardii (McFarland et al., 1995), 20 Escherichia coli Nissle 1917 (Kruis et al., 1997 or some Bacillus species (Duc et al., 2004; Hong et al., 2008) .
During the last ten years, health and wellbeing have been one of the strongest market drivers for the food industry. Therefore, national and supranational regulatory agencies have intervened to warrant the proper use of the terms and concepts also demanding 25 solid scientific evidence for any health claim used in functional foods such as probiotics (http://nccam.nih.gov/health/probiotics/; EU Reglament 1924 . This has reinforced research and remarkable advances have been achieved in our knowledge on targets and modes of action. There are hundreds of scientific publications describing different effects of the probiotic intake in humans, then, meta-analyses and reviews 5 evaluated the level of scientific evidence for clinical use attained by those studies (Gill and Guarner, 2004; Williams, 2010) . Hence, from the clinical perspective, solid scientific evidences on their beneficial effects have made probiotics more and more frequently prescribed in Modern Medicine.
The mechanisms of action of probiotics are mostly unknown, however, they must be 10 necessarily related to their observed effects, and as such, they can be grouped in: antiinfective (treatment or prevention of viral, yeast or bacteria pathogenesis), metabolic functions (amelioration of lactose malabsorption and lowering blood cholesterol) and modulation of the immune response system (improvement of immune response, amelioration of inflammatory syndromes and immune related pathologies). The anti-15 infective effects of probiotic bacteria involve mechanisms that imply antagonism with other bacteria, or competitive binding to receptors, they can also establish an effective communication through biochemical signals with intestinal epithelial cells or mucosa, inducing local defense substances (i.e., IgA) in the mucosa (Corr et al., 2009; Ohland and MacNaughton, 2010) , homeostasis or epithelial integrity (Bäuerl et al., 2011; Di et 20 al., 2005; van Baarlen et al., 2009; van Baarlen et al., 2010) . Those interactions may partially explain the mechanisms used by probiotics to improve immune dysfunctions, where a wide research field has just been opened. However, the study mechanisms of host-probiotic interactions show difficulties that surpass most modern techniques utilized. In particular, their interaction with GALT depends upon multiple receptors 25 4 that, altogether elicit different and complex signal transduction pathways.
Understanding the mechanisms of action of probiotics will help to substantiate Health Claims for commercial purposes, but most important, it will explain differences between strains and will help to define more precisely all aspect of their health benefits.
This review is aimed to compile representative scientific evidence showing the great 5 diversity of applications of probiotics and their future perspectives.
Benefits of probiotics on human health
This far the lack of a homogeneous regulation has led to the coexistence in the market of well studied strains for which health benefits have been demonstrated with others for 10 which not scientific data are available. The new EU regulation on nutrition and health claims made on foods has come into force (Regulation (EC) nº1924/2006) which may help to increase research efforts to scientifically substantiate probiotic effects.
Some of the beneficial effect of probiotic consumption include, among others: improvement of intestinal tract health by means of regulation of microbiota and 15 stimulation and development of the immune system; synthesizing and enhancing the bioavailability of nutrients; reducing symptoms of lactose intolerance and reducing risk of certain diseases. Several mechanisms of action have been proposed to explain the beneficial effects of probiotics. These mechanisms are largely unknown, but may involve modifying gut pH, antagonizing pathogens through production of antimicrobial 20 compounds, competing for pathogen binding, receptor sites, nutrients and growth factors, stimulating immunomodulatory cells, and producing lactase [ref] .
Probiotics have specific targets of action that are probiotic-dependent as different bacterial strains may differ with respect to their effects on health. In addition, it must be taken into consideration that these mechanisms may be multi-factorial processes and 25 5 also, dependent on each probiotic strain that may have specific functions affecting to the health host. Considering their possible targets, probiotics would be designed and applied in specific diseases based on their characteristics and health-promoting effects.
Different levels of host-microbe interaction can be distinguished: i) bacteria-gut epithelium interaction: adhesion to mucosal and epithelial cells, stimulation of mucus 5 secretion and enhancing the production of defensive molecules such as mucins and defensins, increasing and reinforcing barrier function, innate immune function, reducing the secretory and inflammatory consequences of bacterial infection and improving gut motility; ii) bacteria-immune system interaction: Immune-modulation and regulation of immune responses beyond the gut and finally, iii) bacteria-bacteria interaction: 10 Modify microbiota to suppress and inhibit pathogens and prevention of their adhesion, establishment and/or replication of pathogens in the gastrointestinal tract, secretion of antimicrobial substances and compounds, compete for nutrients necessary for pathogen survival and anti-toxin effects. The general mechanisms by which probiotics may have an effect can be divided into three main categories: normalization of microbiota, 15 modulation of immune response, and metabolic functions.
Traditionally probiotics have been tested for several different potential benefits, in the hope that the strain will have some of the tested effects. However, since probiotic health benefits are strain specific, it is likely that strains can be selected aimed at particular groups of consumers. Also particular patient groups may require specific probiotics 20 strains aimed at the groups' particular needs. In addition to efficacy, an assessment of the cost and need for routine use of probiotics should also be conducted in order to identify those areas where probiotics are more likely to be used and they may have a deeper effect. Therefore, an alternative would be to rationally select strains for a specific health benefit. In spite of the lack of scientific rationale on the traditional 25 6 selection procedures, the results of human clinical studies have produced good evidence on the health effects of specific probiotic strains. However, many other proposed health effects still require rigorous clinical studies to prove their health promoting potential. As the use of specially selected new probiotics to maintain health must be considered even more promising, the selection criteria need to be revised. 5
Current Intestinal Applications
Probiotics have been traditionally used in cases of intestinal discomfort. It has been known for a long time that fermented dairy products containing live bacteria are better tolerated than milk by lactose intolerant subjects. Among the current intestinal 10 applications of probiotics the beneficial effects of specific strains shortening the duration and preventing the episodes of diarrhoea are the best documented.
Interestingly, their effect on constipation has also been evaluated. The role of probiotics on inflammatory bowel disease and irritable bowel syndrome has been the subject of several recent studies. During the last years probiotic beneficial effects on Helicobacter 15 pylori infection, colorectal cancer or necrotizing enterocolitis have also been assessed. Some beneficial intestinal effects of certain probiotic strains can be considered well established which has lead to the publication of recommendations for their use in clinical practice (Floch et al. 2008) .
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Lactose intolerance A significant part of the population shows reduced levels of -galactosidase in the small intestine, suffering intolerance symptoms when lactose is ingested. Several studies have shown that lactose-intolerant subjects suffer fewer symptoms if milk is replaced by fermented dairy products. The bacterial enzyme -galactosidase, which can be detected 25 7 in the small intestine after consumption of viable yoghourt, appears to be the major factor improving digestibility by hydrolysing the lactose. It is important to underline that different strains may have very different -galactosidase activities and thus differ in their efficacy. Another factor suggested to have a role is the slower gastric emptying of semi-solid milk products compared with milk. Modulation of the intestinal microbiota 5 composition and activity may also play a role alleviating lactose intolerance (He et al. 2008 ).
Diarrhoea
Diarrhoea is an obvious target for probiotics and their role on infant diarrhoea is the best 10 studied probiotic effect. Several human intervention studies indicate a clear positive effect of specific probiotic strains on both, rotavirus and antibiotic-associated diarrhoea.
In fact, probiotics are considered among the alternatives for management of acute gastroenteritis in children (Guarino et al. 2008) . Results for traveller´s diarrhoea, although encouraging, are less convincing. As with any other probitotic effect the 15 beneficial effects reported in the studies are specific to the strains used.
Roravirus diarrhoea. Shortening the duration of rotavirus diarrhoea using specific probiotic strains is well documented. Several studies around the world reported beneficial effects (Kotowska et al. 2005 , Weizman et al. 2005 , Szymanski et al. 2006 . 20
Some meta-analyses have evaluated the effects of probiotics in general concluding that probiotics reduce the duration or frequency of diarrhoea in children (Huang et al. 2002 , Van Niel et al. 2002 , Allen et al. 2004 . The main criticism to these meta-analyses is that often they considered probiotics as a group. Different probiotics have varying effects on the duration of diarrhoea and the immune response in children with acute 25 8 gastroenteritis. Thus, it is important to remember that the reported studies are specific to the strains used. The increasing number of studies conducted during the last years allowed to carry out meta-analyses focused on specific strains. These studies showed that, at least, the strains Lactobacillus rhamnosus GG and S. boulardii are effective in treatment of acute diarrhoea in children (Sazawal et al. 2006 , Szajewska et al. 2007a . 5
Antibiotic-associated diarrhoea. The efficacy of probiotics reducing this common kind of diarrhoea has been extensively studied and the results are convincing for a number of probiotics. Meta-analyses conducted in this area (Sazawal et al. 2006 , Johnston et al. 2007 ) concluded that the available data provides sufficient evidence for the role of 10 probiotics in the prevention of antibiotic-associated diarrhoea. 
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rhamnosus GG was found to prolonge the relapse-free time, although no effect on relapse rate was observed (Zocco et al. 2006 ) and some positive results have also been reported for S. boulardi (Guslandi et al. 2003) . In contrast, trials evaluating the application of different probiotics on Crohn's disease have not been too successful (Prantera et al. 2002 , Marteau et al. 2006 and only some preliminary studies reported 20 modest beneficial effects (Guslandi et al. 2000 , Guandalini et al. 2002 . Some reviews and meta-analysis studies (Elahi et al. 2007 , Mallon et al. 2007 ) focused on the use of probiotics on IBD concluded that further research is still needed.
Irritable Bowel Syndrome 25
Irritable Bowel Syndrome (IBS) affects a significant part of the western population being the first cause of visit to the gastroenterologist. IBS is characterised by intestinal discomfort or pain and altered bowel function with diarrhoea and constipation.
Although the aetiology if the disease is not well understood, in IBD patients an altered brain response to visceral stimuli appears to occur (Naliboff et al. 2001 ) causing pain or 5 discomfort due to visceral hypersensitivity. An altered gut microbiota has also been reported in IBS patients (Nobaek et al. 2000 , Pimentel at al. 2000 providing the basis for probiotic theraphy. In a study using Lactobacillus plantarum 299v a reduction of symptoms was observed (Niedzelin et al. 2001 ) and reductions of bloating and flatulence have also been reported for the probiotic mix VSL3 (Kim et al. 2003 (Kim et al. , 2005 . johnsonii La1 have been reported to be beneficial (Marteau et al. 2002 , Koebnick et al. 2003 , Fukushima et al. 2004 ).
Necrotizing enterocolitis (NEC)
Recent studies suggest that certain probiotics can reduce both the severity and incidence of NEC in preterm neonates (Hoyos 1999 , Bin-Nun et al. 2005 , Lin et al. 2005 ) whilst no effect has been observed with other probiotic strains (Dani et al. 2002) , underlining the high strain-specificity of probiotics. A meta-analysis study concluded that probiotics 5 may be effective in reducing the risk of NEC in low-birth weight infants but more research is needed to clarify their safety, appropriate dose and type of probiotic to be used (Deshpande et al. 2007 ).
Colorectal cancer 10
Colorectal cancer is the third most common cancer and it seems to be strongly linked to dietary habits (Bingham et al. 2003) . The association between gut microbiota composition and risk of colon cancer has been a subject of discussion for many years rhamnosus GG in the prevention of atopic dermatitis has been reported in randomized, controlled trials (Kalliomaki et al., 2001; 2003) . L. rhamnosus GG was given to pregnant women for four weeks prior to delivery, then to newborns at high risk of allergy for six months with the result that there was a significant reduction in early atopic disease (Kalliomaki, 2003) . In other clinical studies with infants allergic to cow's 15 milk and also, atopic dermatitis was alleviated by ingestion of probiotic strains L. rhamnosus GG and B. lactis Bb12 (Majamaa and Isolauri, 1996; 1997; Isolauri et al., 2000) . Furthermore, several well-designed studies have provided evidence that specific strains of probiotics can be somewhat effective in treatment of established atopic dermatitis (Rosenfeldt et al. 2003; Viljanen et al. 2005; Weston et al. 2005) . In other 20 studies, L. rhamnosus GG was combinated with other probiotic strains, L. rhamnosus LC705, B. breve Bb99, and Propionibacterium freudenreichii subsp. shermanii JS in order to determine the impact on the cumulative incidence of allergic diseases (Kukkonen et al. 2007 ). This study showed no effect on incidence of all allergic diseases, but the treatment did significantly prevent atopic eczema. Two studies 25 16 showed a preventive effect of probiotic supplementation on the development of eczema at the age of 2 years, with a relative risk reduction of 50% (Kalliomaki et al., 2001 ) and 26% (Kukkonen et al., 2007) . In a third study, the cumulative incidence of eczema was similar in intervention and placebo group, but less atopic eczema was observed in the intervention group (Abrahamsson et al., 2007) . In two studies, supplementation of 5 probiotic bacteria failed to reduce the risk of atopic dermatitis and resulted in increased sensitization to allergens in one study (Taylor et al., 2007; Kopp et al., 2008) . A major reason for these discrepant clinical results may be the use of different probiotic strains or preparations. In this respect, however, it is interesting that the results of Kopp et al. prospective, double blind, controlled trial was conducted (Giovanini et al, 2007) . In children with rhinitis, the annual number of rhinitis episodes was lower in the 10 intervention group, and also the mean duration of an episode of diarrhea was lower in the intervention group. While long-term consumption of fermented milk containing Lactobacillus casei may improve the health status of children with allergic rhinitis no effect was found in asthmatic children (Giovanini et al, 2007) .
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Oral cavity
The microflora of the oral cavity is comprised of more than 500 bacterial species (Dewhirst et al. 2009 ). The most prominent cariogenic bacterium is Streptococcus mutans, but many lactobacilli have cariogenic properties too. The composition of the oral microflora is influenced by bacterial transfer at birth, the gastrointestinal flora, the 20 composition of the saliva and by other factors. The long-term composition is remarkably stable and does not vary with individual meals. The main focus in the studies of potential oral probiotics has been on caries prevention, especially on the possibility of reducing the number of mutans streptococci when products containing certain probiotic strains are used (Haukioja et al., 2008) . The caries bacteria colonize 25 acidic environments, such as fissures and interdental spaces, and produce acids from fermentable sugars. On the contrary there was a suggestion that temporary colonization of a nonlactose and slow sugar fermenting bacteria, which are able to inhibit the caries pathogens, may prevent caries in children (Meurman et al., 1994 , Nasse et al., 2001 ).
Other possible applications, like the reduction of the number of oral Candida or of 5 microflora associated with oral malodour, have also been investigated.
The probiotic strains most studied in relation to the colonization of mutans streptococci are L. rhamnosus GG and L. reuteri ATCC 55730 (Ahola et al., 2002; Caglar et al., 2005 Caglar et al., , 2006 Meurman et al., 1995; Näse et al., 2001; Nikawa et al., 2001) . In some studies the use of products containing these bacteria has been found to reduce oral 10 mutans streptococci (Näse et al., 2001; Nikawa et al., 2001; Caglar et al., 2006) . L.
rhamnosus GG can be found in the oral cavities of volunteers who are using products containing this bacterium (Yli-Knuuttila et al., 2006) . Colonization by L. reuteri SD2112 has not been studied, but the products containing it do not increase the lactobacillus counts in saliva (Canglar et al., 2006) . Other probiotic strains have also 15 been studied but with contradictory results: for example, a product containing Although several studies have shown that some probiotic bacteria may affect oral 20 ecology, the mechanisms are largely unknown. A recent study (Haukioja et al., 2008) showed that probiotic bacteria that bound to saliva-coated hydroxyapatite reduced the adhesion of S. mutans but the inhibitory effect on the adherence of S. gordonii was lower. Salivary pellicle protein composition was modified by all the strains tested.
Further studies are needed on this filed to clarify the potential role of probiotics. 25
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Skin diseases
The normal human skin microflora is variable according to location and composed of a limited number of microbial types (Grice et al. 2009 ). The resident microbiota fills a niche that could otherwise be colonized by pathogenic microorganisms that are 5 aggressive and cause infection, either at the skin site or by transfer to other sites. Also, if the skin could be colonized by pathogens adopted for other sites (e.g. mucous membranes), and this could facilitate the spread of pathogens by offering them more dispersed routes.
As stated above, a significant improvement on the course of atopic dermatitis (Isolauri 10 et al., 2000) and also, probiotics may be able to reduce the prevalence of atopic eczema in children at high risk for atopic diseases (Kalliomaki et al., 2001 ) have been described.
The suggested mechanistic base of skin effects induced by probiotic strains is represented by changes in systemic immune responses. In particular, modulation of specific T-cell subsets such as stimulation of TH1 cells in the gut mucosa which may 15 subsequently influence immune responses in other tissues may play a role (Pohjavuori et al., 2004; Lammers et al., 2003 , Prescott et al., 2005 . In mice, oral administration of Lactobacillus casei reduced contact hypersensitivity to a hapten only in the presence of CD4+ T-cells, which control the size of the CD8+ effector pool (Chapat et al., 2004) .
Nutritional supplementation of mice with Lactobacillus johnsonii provided protection of 20 the skin immune system against ultraviolet B radiation-induced immunosuppressive effects (Gueniche et al., 2006) . Similar effects have recently been described in a human in vivo study and it has been proposed that oral consumption of probiotic bacteria may represent a novel approach to protect the skin immune system against ultraviolet radiation (Bouilly et al.,2008) . Another target for probiotics may be skin barrier 25 function. A recent double-blind, randomized clinical study has shown that a 24-week skin nutrition intervention with a fermented dairy product in female volunteers having dry and sensitive, but otherwise healthy skin significantly reduced transepidermal water loss and thus improved stratum corneum barrier function compared to a placebo product (Punch et al., 2008) . It should be noted, however, that in addition to the probiotic strains 5 (L. casei, Lactobacillus bulgaris and Streptococcus thermophilus) this dairy product contained a mixture of boretsch oil, green tea polyphenols and vitamin E and that skin barrier improvement may be at least in part due to these ingredients. In general, nonintestinal applications of probiotics are few and have thus far mainly been used for the urogenital tract. There are currently only a very few studies pursuing a probiotic 10 approach for the skin bacterial composition. Ouwehand et al. (2003) point out the difficulty to identify useful bacteria in view of the environmental conditions that may prevent colonization of skin with a probiotic strain.
Obesity and Insulin Control 15
The prevalence of obesity is rapidly increasing in Western society, constituting an important health issue. Obesity is the result of a positive imbalance between energy intake and energy expenditure over a long period of time and its related to the development of other diseases including diabetes and cardiovascular diseases among others. Several genetic and environmental factors influence obesity (Hill et al., 1998; 20 Jouret et al., 2007) which include diet, socioeconomic status, maternal obesity, rapid infancy weight gain, and decreased physical activity. In addition to all of these risks, some reports have suggested that the gut microbiota is an important factor affecting energy disposal and storage in adipocytes (Ley et al., 2005 , Turnbaugh et al., 2006 . In addition, a recent report showed that infants with high numbers of the Bifidobacterium and low numbers of Staphylococcus may be protected from excess weight gain during later life (Kalliomaki et al., 2008) . Since Bifidobacterium genus and 10 species are prevalent in breast-fed infants, it has been suggested the protective role attributed to breast-milk against developing obesity later in life (Wabitsh 2000) . In addition, it has been reported how diets based on a high intake of protein and/or low intake of carbohydrate or low fat consumption may alter microbial composition and activity in the large intestine and thus impact on gut health (Cani et al., 2008 , Duncan et 15 al., 2007 . Obese humans under dietary intervention, based on low carbohydrate intake and high protein intake, showed reductions in Bifidobacterium, and Roseburia spp. and clostridial cluster XIVa levels when carbohydrate intake was decreased, while no differences were detected in Bacteroides or other clostridial clusters (Duncan et al., 2007) . Alterations in gut microbiota composition associated with obesity have also been 20 shown to be reversible by oral transfer of the gut microbiota from lean mice to a germfree recipient (Turnbaugh et al., 2006 and 2008) or by administration of prebiotic substrates to animal models at least over short-term periods (Cani et al., 2007) .
Therefore, it seems likely that a combination of environmental (e.g. diet) and genetic factors contributes to defining unique combinations of bacteria within an individual, which could favor either an obese or lean phenotype.
Gut microbiota modulation via dietary strategies such as probiotics may offer new directions for preventive and therapeutic applications in reducing the risk of overweight and obesity and also, metabolic-associated disorders. Lee et al (2006) investigated the 5 anti-obesity effect of a L. rhamnosus strain that produces conjugated linoleic acid, in diet-induced obese mice. After 8 weeks of oral feeding, mice lost weight without reducing energy intake. In another study, Martin et al (2008) administered probiotic beverages to germ-free mice that had been conventionalized with human infant microbiota showed that probiotic exposure resulted in distinct changes in the 10 microbiome with associated metabolic alterations affecting energy, lipid, and aminoacid metabolism. The importance of these findings to energy homeostasis and overall health in humans remains to be determined; however, they suggest that probiotics can alter the dynamics of the entire gut microbiota and show that these molecular approaches can be used to study the metabolic effects of probiotics on the host and the host's microbiome. and aberrancies on the intestinal microbiota composition have been identified in arthritis (Benno et al. 1994 , Malin et al. 1996 and spondylitis (Stebbings et al. 2002) . The rapid development of massive sequencing techniques is allowing the flourisment of metagenomic studies. The increased knowledge on genomics, microbiota, and 20 interactions nutrients-genes (nutrigenomics) promises to expand our understanding on the interactions between food and health allowing the development of probiotic dietary intervention strategies tailored for specific individuals or functions. This is increasing enormously our knowledge on the complex gut microbiota composition and activities and allowing to identify disturbances on microbiota related to human disease. In general 25 25 any disorder in which an aberrant microbiota or an un-appropriate immune response may play a role are potential targets for probiotic intervention, even though they may not take place at gut level. Disturbances on the microbiota have been identified in other intestinal disorders, including diverticulitis (Colecchia et al. 2003) , and extraintestinal conditions, such as elderly people suffering severe frailty (van Tongeren et al. 2005) . 5
Patients with severe systemic inflammatory response syndrome showed lower levels of bifidobacteria and lactobacilli and higher levels of pathogenic microorganisms than healthy subjects (Shimizu et al. 2006) . Reduced levels of bifidobacteria have also been shown in multiple sclerosis patients (Wagenfeld 1991). Although, so far probiotics have not been tested in these settings, these studies indicate potential targets for the future 10 development of probiotic products.
Some intestinal bacteria have been suggested for very specific targets. For instance
Oxalobacter formigenes may have a potential role to play in the risk reduction for kidney stone formation. (Stewart et al. 2004) . A Bacteroides strain, able to reduce cholesterol, isolated from the gut microbiota of a subject with a high ability to reduce 15 cholesterol to coprostanol has also been reported (Gerard et al. 2007 ). Such microorganisms may constitute the basis for future targeted probiotic developments. To this regard, other areas of the body different to the gastrointestinal and urogenital tracts, such as nasopharynx or skin may also provide areas for novel probiotic applications.
In any case the high strain-specificity of probiotics must always be taken into 20 consideration. In fact, the strain-specific characteristics can be exploited to select more efficacious strains or for selecting probiotics for specific targets or populations.
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